- Joined
- Jun 20, 2005
- Messages
- 8,022
- Reaction score
- 2,816
An interesting review article that appeared in Medscape this week:
Medscape: Medscape Access
In conclusion, there is moderate evidence that perineural dexamethasone combined with bupivacaine but not with ropivacaine slightly prolongs the duration of analgesia when compared with systemic dexamethasone, without an impact on the other secondary pain-related outcomes. The administration of dexamethasone in this setting should be balanced properly with recognition of the off-label indication of perineural administration and with consideration for the possibility of crystallization when combined with ropivacaineInteresting review article in Medscape this week.
Will this change your practice?
Medscape: Medscape Access
In conclusion, there is moderate evidence that perineural dexamethasone combined with bupivacaine but not with ropivacaine slightly prolongs the duration of analgesia when compared with systemic dexamethasone, without an impact on the other secondary pain-related outcomes. The administration of dexamethasone in this setting should be balanced properly with recognition of the off-label indication of perineural administration and with consideration for the possibility of crystallization when combined with ropivacaineInteresting review article in Medscape this week.
Will this change your practice?